1. Home
  2. VTAK vs MOVE Comparison

VTAK vs MOVE Comparison

Compare VTAK & MOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTAK
  • MOVE
  • Stock Information
  • Founded
  • VTAK 2002
  • MOVE 2018
  • Country
  • VTAK United States
  • MOVE United States
  • Employees
  • VTAK N/A
  • MOVE N/A
  • Industry
  • VTAK Medical/Dental Instruments
  • MOVE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • VTAK Health Care
  • MOVE Health Care
  • Exchange
  • VTAK Nasdaq
  • MOVE Nasdaq
  • Market Cap
  • VTAK 3.9M
  • MOVE 4.5M
  • IPO Year
  • VTAK 2018
  • MOVE 2021
  • Fundamental
  • Price
  • VTAK $3.04
  • MOVE $0.74
  • Analyst Decision
  • VTAK
  • MOVE Buy
  • Analyst Count
  • VTAK 0
  • MOVE 1
  • Target Price
  • VTAK N/A
  • MOVE $30.00
  • AVG Volume (30 Days)
  • VTAK 3.1M
  • MOVE 133.7K
  • Earning Date
  • VTAK 08-11-2025
  • MOVE 09-02-2025
  • Dividend Yield
  • VTAK N/A
  • MOVE N/A
  • EPS Growth
  • VTAK N/A
  • MOVE N/A
  • EPS
  • VTAK N/A
  • MOVE N/A
  • Revenue
  • VTAK $600,000.00
  • MOVE $1,013,000.00
  • Revenue This Year
  • VTAK $822.86
  • MOVE $1,460.71
  • Revenue Next Year
  • VTAK $168.42
  • MOVE $96.77
  • P/E Ratio
  • VTAK N/A
  • MOVE N/A
  • Revenue Growth
  • VTAK 37.62
  • MOVE N/A
  • 52 Week Low
  • VTAK $2.49
  • MOVE $0.51
  • 52 Week High
  • VTAK $43.70
  • MOVE $6.97
  • Technical
  • Relative Strength Index (RSI)
  • VTAK 44.02
  • MOVE 60.03
  • Support Level
  • VTAK $2.70
  • MOVE $0.57
  • Resistance Level
  • VTAK $4.31
  • MOVE $0.63
  • Average True Range (ATR)
  • VTAK 0.37
  • MOVE 0.06
  • MACD
  • VTAK 0.03
  • MOVE 0.01
  • Stochastic Oscillator
  • VTAK 30.22
  • MOVE 80.93

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

About MOVE Movano Inc.

Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.

Share on Social Networks: